These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 9093271
21. Botulinum toxin in the treatment of zygomatic fractures. Kayikçioğlu A, Erk Y, Mavili E, Vargel I, Ozgür F. Plast Reconstr Surg; 2003 Jan; 111(1):341-6. PubMed ID: 12496600 [No Abstract] [Full Text] [Related]
22. Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome. Dressler D, Wittstock M, Benecke R. Eur Neurol; 2001 Jan; 45(4):287-8. PubMed ID: 11385272 [No Abstract] [Full Text] [Related]
23. Use of mirror dystonia as guidance for injection of botulinum toxin in writing dysfunction. Singer C, Papapetropoulos S, Vela L. J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1608-9. PubMed ID: 16227568 [No Abstract] [Full Text] [Related]
24. Botulinum toxin for masseter hypertrophy. Al-Muharraqi MA, Fedorowicz Z, Al Bareeq J, Al Bareeq R, Nasser M. Cochrane Database Syst Rev; 2009 Jan 21; (1):CD007510. PubMed ID: 19160335 [Abstract] [Full Text] [Related]
25. Active upper-limb movement can be improved in hemiplegic patients by botulinum toxin injection. Yelnik A. J Neurol Neurosurg Psychiatry; 2010 Apr 21; 81(4):357. PubMed ID: 20360163 [No Abstract] [Full Text] [Related]
27. Dilution, storage, and electromyographic guidance in the use of botulinum toxins. Mantell AM. Dermatol Clin; 2004 Apr 21; 22(2):135-6, v. PubMed ID: 15222572 [Abstract] [Full Text] [Related]
28. Botulinum toxin type A for treatment of spasticity in spinocerebellar ataxia type 3 (Machado-Joseph disease). Freeman W, Wszolek Z. Mov Disord; 2005 May 21; 20(5):644. PubMed ID: 15747361 [No Abstract] [Full Text] [Related]
29. [Botulinum toxin injections for facial rejuvenation]. Société Française de Chirurgie Plastique Reconstructrice et Esthétique. Ann Chir Plast Esthet; 2004 Oct 21; 49(5):553-6. PubMed ID: 15600009 [No Abstract] [Full Text] [Related]
30. The use of botulinum toxin type A in aesthetic mandibular contouring. Kim NH, Chung JH, Park RH, Park JB. Plast Reconstr Surg; 2005 Mar 21; 115(3):919-30. PubMed ID: 15731696 [Abstract] [Full Text] [Related]
31. Treatment of severe post-traumatic bruxism with botulinum toxin-A: case report. Pidcock FS, Wise JM, Christensen JR. J Oral Maxillofac Surg; 2002 Jan 21; 60(1):115-7. PubMed ID: 11757023 [No Abstract] [Full Text] [Related]
32. Aesthetic uses of botulinum toxin A. Niamtu J. J Oral Maxillofac Surg; 1999 Oct 21; 57(10):1228-33. PubMed ID: 10513870 [No Abstract] [Full Text] [Related]
33. OnabotulinumtoxinA Injections for Urge Incontinence. Hubb AJ, Stachowicz AM, Wood SC. Am Fam Physician; 2018 Feb 01; 97(3):Online. PubMed ID: 29431973 [No Abstract] [Full Text] [Related]
34. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series. Baker JS, Nolan PJ. J Am Dent Assoc; 2017 Jan 01; 148(1):33-39. PubMed ID: 28314397 [Abstract] [Full Text] [Related]
35. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique. Guarda-Nardini L, Stecco A, Stecco C, Masiero S, Manfredini D. Cranio; 2012 Apr 01; 30(2):95-102. PubMed ID: 22606852 [Abstract] [Full Text] [Related]
36. Question 2: is there any long-term benefit from injecting botulinum toxin-A into children with cerebral palsy? Bradley LJ, Huntley JS. Arch Dis Child; 2014 Apr 01; 99(4):392-4. PubMed ID: 24626322 [No Abstract] [Full Text] [Related]
37. Myofascial pain. Malcmacher L. Dent Today; 2013 Dec 01; 32(12):16. PubMed ID: 24494450 [No Abstract] [Full Text] [Related]
38. Use of botulinum toxin A for treatment of myofascial pain and dysfunction. Fallah HM, Currimbhoy S. J Oral Maxillofac Surg; 2012 May 01; 70(5):1243-5. PubMed ID: 22538024 [No Abstract] [Full Text] [Related]
39. Injection of botulinum toxin for treatment of chronic lateral epicondylitis: systematic review and meta-analysis. Galvin R, Callaghan C, Chan WS, Dimitrov BD, Fahey T. Semin Arthritis Rheum; 2011 Jun 01; 40(6):585-7. PubMed ID: 21397930 [No Abstract] [Full Text] [Related]
40. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment. Xie Y, Zhou J, Li H, Cheng C, Herrler T, Li Q. Plast Reconstr Surg; 2014 Aug 01; 134(2):209e-218e. PubMed ID: 25068343 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]